Carlsmed, a spine medtech company, launched its initial public offering of 6.7 million shares of common stock, according to a June 15 news release.
Common stock price is expected to be between $14 and $16 per share, and the company applied to be listed on the Nasdaq Global Select Market.
Carlsmed is behind aprevo personalized spine implants. The company filed for the IPO in June, and BofA Securities, Goldman Sachs & Co. LLC and Piper Sandler are the joint lead book-running managers and representatives.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
